Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Swanstrom

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
Trends in Microbiology|April 20, 2016
Improving Viral Protease Inhibitors to Counter Drug ResistanceNese Kurt Yilmaz, Ronald Swanstrom, Celia A Schiffer
Journal of Virology|November 16, 2007
Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteinsMilloni B Patel, Noah G Hoffman, Ronald Swanstrom
Journal of Virology|December 18, 2009
Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infectionGretja Schnell, Richard W Price, Ronald Swanstrom, et al.
Handbook of Experimental Pharmacology|December 3, 2008
Viral protease inhibitorsJeffrey Anderson, Celia Schiffer, Sook-Kyung Lee, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Cotranslational folding and maturation of HIV-1 proteaseJustin Westerfield, Felix Nicolaus, Ronald Swanstrom, et al.
Current Topics in Microbiology and Immunology|March 18, 2015
The triple threat of HIV-1 protease inhibitorsMarc Potempa, Sook-Kyung Lee, Richard Wolfenden, et al.
Journal of Molecular Biology|April 4, 2026
Cotranslational folding and "constrained monomers" in the maturation of HIV-1 proteaseJustin M Westerfield, Felix Nicolaus, Ronald Swanstrom, et al.
Journal of Virology|August 7, 2002
Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantlyWolfgang Resch, Rainer Ziermann, Neil Parkin, et al.
Journal of Virology|June 16, 2005
Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cellsPatrick R Harrington, David W Haas, Kimberly Ritola, et al.
Journal of Virology|July 30, 2005
Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavirWolfgang Resch, Neil Parkin, Terri Watkins, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Trends in Microbiology|April 20, 2016
Improving Viral Protease Inhibitors to Counter Drug ResistanceNese Kurt Yilmaz, Ronald Swanstrom, Celia A Schiffer
Journal of Virology|November 16, 2007
Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteinsMilloni B Patel, Noah G Hoffman, Ronald Swanstrom
Journal of Virology|December 18, 2009
Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infectionGretja Schnell, Richard W Price, Ronald Swanstrom, et al.
Handbook of Experimental Pharmacology|December 3, 2008
Viral protease inhibitorsJeffrey Anderson, Celia Schiffer, Sook-Kyung Lee, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Cotranslational folding and maturation of HIV-1 proteaseJustin Westerfield, Felix Nicolaus, Ronald Swanstrom, et al.
Current Topics in Microbiology and Immunology|March 18, 2015
The triple threat of HIV-1 protease inhibitorsMarc Potempa, Sook-Kyung Lee, Richard Wolfenden, et al.
Journal of Molecular Biology|April 4, 2026
Cotranslational folding and "constrained monomers" in the maturation of HIV-1 proteaseJustin M Westerfield, Felix Nicolaus, Ronald Swanstrom, et al.
Journal of Virology|August 7, 2002
Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantlyWolfgang Resch, Rainer Ziermann, Neil Parkin, et al.
Journal of Virology|June 16, 2005
Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cellsPatrick R Harrington, David W Haas, Kimberly Ritola, et al.
Journal of Virology|July 30, 2005
Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavirWolfgang Resch, Neil Parkin, Terri Watkins, et al.
Pageof 18